3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Interventions
Cytarabine
89
Daunorubicin
45
Azacitidine
43
Idarubicin
27
venetoclax
26
fludarabine
26
Etoposide
25
Cyclophosphamide
25
Mitoxantrone
22
Decitabine
19
Busulfan
19
Methotrexate
16
Gemtuzumab
14
Granulocyte Colony-Stimulating Factor
12
Whole-Body Irradiation
10
Peripheral Blood Stem Cell Transplantation
10
Melphalan
10
gilteritinib
9
Filgrastim
9
fludarabine phosphate
8
Tacrolimus
8
Mycophenolic Acid
8
Cyclosporine
8
Tretinoin
7
Radiotherapy
7
Drug Therapy
7
Observation
6
Homoharringtonine
6
Antilymphocyte Serum
6
quizartinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, Myeloid, Acute
×
Nalbuphine
×
Clear all
NCT03825887
2021-08-02
PCA
Children's Cancer Hospital Egypt 57357
Phase 3
Completed
80 enrolled